InsidersTradesSigma
Follow the 지투지바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 지투지바이오 has recorded 6 insider filings. Market capitalisation: €750.3bn. The latest transaction was filed on 5 June 2026 (Other). Among the most active insiders: 이희용. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.